Company Offering Services to Medical Device Developers in the Areas of Technology Development, Clinical Investigations, and Business Consulting


What is go.Med?

go.Med will be founded by the end of 2022. It is an acceleration platform specialized in the development of high-risk medical devices (Class IIb and Class III). It bundles a set of services under its name offering the unique opportunity to access all these services through one single entry point.

Services

We will support you throughout the development phases from concept phase to clinical investigation phase. TRL_New.png

Customer Journey

A key account manager (KAM) will personally interact with you and help you define the services that meet your needs. A virtual platform will facilitate the interaction and information exchange from the first contact onwards.

Information flyers - Accelerating High-Risk Medical Device Development

Service Portfolio

Concept Phase

An initial assessment, including regulatory aspects, market and technology.

Development Phase

Expert research and development advice to help you in the preclinical proof of concept.

Validation Phase

Preparing your medical device for clinical testing

Clinical Investigation Phase

Starting from the design of the clinical proof of concept to the execution of clinical investigations.

Methodology

Quality by Design

go.Med applies a Quality by Design (QbD) methodology, a risk based approach, providing the tools to generate deep knowledge on device performance and the manufacturing processes.

easyQbD platform

Experts Involved in go.Med

go.Med gathers experts from different fields that have been working together in the past to establish and optimize the services offered. This unique set of collaboration is the advantage that you gain when working with us in go.Med.